The long term use of proton pump inhibitors (PPIs), a class of drugs widely used to treat acid reflux and ulcers, may not be linked to any increased risk of developing gastric (stomach) cancer, finds ...

Since their development and widespread adoption in the late 1980s, proton pump inhibitors (PPI) have transformed the field of gastroenterology. Their high efficacy and favorable safety profiles have ...

The potential link between use of proton pump inhibitors and gastric cancer has been an ongoing controversial subject since the drugs entered the market in the late 1980s. Long-term use of proton pump ...

The long term use of proton pump inhibitors (PPIs), a class of drugs widely used to treat acid reflux and ulcers, may not be linked to any increased risk of developing gastric (stomach) cancer, finds ...

A large segment of the CYP2C19 rapid metabolizer subgroup is nonresponder to the PPI treatment, only partial symptom relief in GERD, more frequent unsuccessful eradication therapy and lower healing ...

What are the consequences of taking proton pump inhibitors (PPIs) over an extended period of time? It seems we start patients on these medications and never discontinue them. — CHERIE HOWK, PhD, ...

Effect of PD-1/ PD-L1 and statin combination therapy on gastrointestinal toxicity related to immune checkpoint inhibitors and on survival. This is an ASCO Meeting Abstract from the 2024 ASCO ...

Use of PPIs or antibiotics was linked with worse overall survival in patients with renal cell carcinoma treated with immune checkpoint inhibitors. Specific concomitant medications are linked with ...

"The finding of no association may offer relief for patients who need long-term proton pump inhibitor therapy in the treatment of gastroesophageal reflux disease or for other clear indications." ...

Sources of error that may lead to false association include PPI use shortly before diagnosis, short-term PPI use. (HealthDay News) — Long-term proton pump inhibitor ...